HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 23-OCT-20 7KI9 TITLE CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE (DHFR) FROM MYCOBACTERIUM TITLE 2 ULCERANS AGY99 IN COMPLEX WITH NADP AND INHIBITOR SDDC-0001912 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.5.1.3; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM ULCERANS (STRAIN AGY99); SOURCE 3 ORGANISM_TAXID: 362242; SOURCE 4 STRAIN: AGY99; SOURCE 5 GENE: DFRA, MUL_2179; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: MYULA.01062.A.B13 KEYWDS SSGCID, SDDC, INHIBITOR, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL KEYWDS 2 GENOMICS CENTER FOR INFECTIOUS DISEASE, OXIDOREDUCTASE, KEYWDS 3 OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID) REVDAT 2 18-OCT-23 7KI9 1 REMARK REVDAT 1 07-JUL-21 7KI9 0 JRNL AUTH J.A.ABENDROTH,D.M.DRANOW,R.M.ZIGWEID,D.D.LORIMER, JRNL AUTH 2 P.S.HORANYI,T.E.EDWARDS JRNL TITL CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE (DHFR) FROM JRNL TITL 2 MYCOBACTERIUM ULCERANS AGY99 IN COMPLEX WITH NADP AND JRNL TITL 3 INHIBITOR SDDC-0001912 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19RC2 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 37929 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.136 REMARK 3 R VALUE (WORKING SET) : 0.134 REMARK 3 FREE R VALUE : 0.165 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.230 REMARK 3 FREE R VALUE TEST SET COUNT : 1983 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.4000 - 3.0100 0.99 2623 133 0.1271 0.1624 REMARK 3 2 3.0100 - 2.3900 0.99 2589 132 0.1436 0.1334 REMARK 3 3 2.3900 - 2.0900 0.99 2557 133 0.1285 0.1606 REMARK 3 4 2.0900 - 1.9000 1.00 2586 145 0.1238 0.1574 REMARK 3 5 1.9000 - 1.7600 1.00 2576 141 0.1299 0.1447 REMARK 3 6 1.7600 - 1.6600 1.00 2536 155 0.1318 0.1656 REMARK 3 7 1.6600 - 1.5700 1.00 2564 147 0.1229 0.1875 REMARK 3 8 1.5700 - 1.5100 1.00 2571 126 0.1206 0.1807 REMARK 3 9 1.5100 - 1.4500 1.00 2570 153 0.1299 0.1806 REMARK 3 10 1.4500 - 1.4000 1.00 2580 128 0.1375 0.1790 REMARK 3 11 1.4000 - 1.3500 1.00 2567 163 0.1534 0.2036 REMARK 3 12 1.3500 - 1.3200 1.00 2555 147 0.1633 0.2144 REMARK 3 13 1.3200 - 1.2800 1.00 2570 131 0.1700 0.2198 REMARK 3 14 1.2800 - 1.2500 0.98 2502 149 0.1828 0.1912 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.110 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 15.160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.34 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7KI9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1000252520. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97872 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37934 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.250 REMARK 200 RESOLUTION RANGE LOW (A) : 35.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.641 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.98 REMARK 200 R MERGE FOR SHELL (I) : 0.48800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.280 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NAD AND P218-BOUND STRUCTURE, PDB ENTRY 6UWW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MICROLYTIC MORPHEUS SCREEN, CONDITION REMARK 280 A5: 10% (W/V) PEG 20000, 20% (V/V) PEG MME 550: 30MM EACH MGCL2, REMARK 280 CACL2: 100MM MOPS / HEPES PH 7.5: MYULA.01062.A.B13.PS38558 AT REMARK 280 7.98MG/ML + 2.5MM NADP + 2.5MM SDDC-0001912 (BSI111355): TRAY REMARK 280 318201 A5: CRYO: DIRECT: PUCK UCX6-7, PH 6.5, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 287K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.39500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -7 REMARK 465 ALA A -6 REMARK 465 HIS A -5 REMARK 465 GLU A 92 REMARK 465 PRO A 93 REMARK 465 ASP A 94 REMARK 465 ALA A 95 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A -4 CG ND1 CD2 CE1 NE2 REMARK 470 MET A 1 CG SD CE REMARK 470 THR A 2 OG1 CG2 REMARK 470 ARG A 152 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 23 33.53 -86.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue WFJ A 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: SSGCID-MYULA.01062.A RELATED DB: TARGETTRACK DBREF 7KI9 A 1 165 UNP A0PQG8 A0PQG8_MYCUA 1 165 SEQADV 7KI9 MET A -7 UNP A0PQG8 EXPRESSION TAG SEQADV 7KI9 ALA A -6 UNP A0PQG8 EXPRESSION TAG SEQADV 7KI9 HIS A -5 UNP A0PQG8 EXPRESSION TAG SEQADV 7KI9 HIS A -4 UNP A0PQG8 EXPRESSION TAG SEQADV 7KI9 HIS A -3 UNP A0PQG8 EXPRESSION TAG SEQADV 7KI9 HIS A -2 UNP A0PQG8 EXPRESSION TAG SEQADV 7KI9 HIS A -1 UNP A0PQG8 EXPRESSION TAG SEQADV 7KI9 HIS A 0 UNP A0PQG8 EXPRESSION TAG SEQADV 7KI9 SER A 89 UNP A0PQG8 CYS 89 ENGINEERED MUTATION SEQADV 7KI9 ALA A 96 UNP A0PQG8 GLU 96 ENGINEERED MUTATION SEQRES 1 A 173 MET ALA HIS HIS HIS HIS HIS HIS MET THR SER VAL GLY SEQRES 2 A 173 LEU ILE TRP ALA GLN SER THR SER GLY VAL ILE GLY ARG SEQRES 3 A 173 ASP GLY GLY ILE PRO TRP ARG LEU PRO GLU ASP LEU ALA SEQRES 4 A 173 HIS PHE LYS ARG LEU THR MET GLY HIS THR VAL VAL MET SEQRES 5 A 173 GLY ARG ARG THR TRP ASP SER LEU PRO ALA ALA HIS ARG SEQRES 6 A 173 PRO LEU PRO GLY ARG ARG ASN VAL VAL VAL THR ARG GLN SEQRES 7 A 173 THR GLY LEU VAL ALA HIS GLY ALA GLN VAL VAL GLY SER SEQRES 8 A 173 LEU GLU GLN ALA LEU SER PRO ALA GLU PRO ASP ALA ALA SEQRES 9 A 173 THR TRP VAL ILE GLY GLY ALA GLN ILE TYR ALA LEU ALA SEQRES 10 A 173 LEU PRO LEU ALA ASN ARG CYS GLU VAL THR GLU VAL ASP SEQRES 11 A 173 VAL ASP LEU PRO PRO GLU ASP GLU ASP ALA LEU ALA PRO SEQRES 12 A 173 VAL LEU ASP GLN THR TRP ALA GLY THR SER GLY GLU TRP SEQRES 13 A 173 LEU VAL SER ARG SER GLY LEU ARG TYR ARG MET HIS SER SEQRES 14 A 173 TYR ARG ARG LEU HET NAP A 201 48 HET WFJ A 202 31 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM WFJ 1-[2-(3-{[(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL) HETNAM 2 WFJ OXY]METHYL}AZETIDIN-1-YL)PHENYL]PIPERIDINE-4- HETNAM 3 WFJ CARBOXYLIC ACID HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 WFJ C22 H30 N6 O3 FORMUL 4 HOH *210(H2 O) HELIX 1 AA1 LEU A 26 MET A 38 1 13 HELIX 2 AA2 ARG A 46 LEU A 52 1 7 HELIX 3 AA3 PRO A 53 ARG A 57 5 5 HELIX 4 AA4 SER A 83 SER A 89 1 7 HELIX 5 AA5 GLY A 102 LEU A 110 1 9 HELIX 6 AA6 PRO A 111 ALA A 113 5 3 SHEET 1 AA1 8 GLN A 79 VAL A 81 0 SHEET 2 AA1 8 ARG A 63 VAL A 67 1 N VAL A 66 O GLN A 79 SHEET 3 AA1 8 THR A 41 GLY A 45 1 N VAL A 42 O VAL A 65 SHEET 4 AA1 8 THR A 97 VAL A 99 1 O TRP A 98 N VAL A 43 SHEET 5 AA1 8 VAL A 4 SER A 11 1 N GLY A 5 O VAL A 99 SHEET 6 AA1 8 ARG A 115 ASP A 122 1 O THR A 119 N GLN A 10 SHEET 7 AA1 8 ARG A 156 ARG A 164 -1 O ARG A 158 N GLU A 120 SHEET 8 AA1 8 TRP A 141 SER A 145 -1 N THR A 144 O SER A 161 SHEET 1 AA2 8 GLN A 79 VAL A 81 0 SHEET 2 AA2 8 ARG A 63 VAL A 67 1 N VAL A 66 O GLN A 79 SHEET 3 AA2 8 THR A 41 GLY A 45 1 N VAL A 42 O VAL A 65 SHEET 4 AA2 8 THR A 97 VAL A 99 1 O TRP A 98 N VAL A 43 SHEET 5 AA2 8 VAL A 4 SER A 11 1 N GLY A 5 O VAL A 99 SHEET 6 AA2 8 ARG A 115 ASP A 122 1 O THR A 119 N GLN A 10 SHEET 7 AA2 8 ARG A 156 ARG A 164 -1 O ARG A 158 N GLU A 120 SHEET 8 AA2 8 LEU A 149 VAL A 150 -1 N LEU A 149 O TYR A 157 SHEET 1 AA3 2 VAL A 15 GLY A 17 0 SHEET 2 AA3 2 ALA A 132 LEU A 133 -1 O ALA A 132 N ILE A 16 CISPEP 1 ARG A 57 PRO A 58 0 -0.25 CISPEP 2 SER A 89 PRO A 90 0 -1.19 CISPEP 3 GLY A 101 GLY A 102 0 1.90 SITE 1 AC1 36 TRP A 8 ALA A 9 ILE A 16 GLY A 17 SITE 2 AC1 36 ARG A 18 GLY A 21 ILE A 22 GLY A 45 SITE 3 AC1 36 ARG A 46 ARG A 47 THR A 48 VAL A 67 SITE 4 AC1 36 THR A 68 ARG A 69 GLN A 70 GLY A 82 SITE 5 AC1 36 ILE A 100 GLY A 101 GLY A 102 ALA A 103 SITE 6 AC1 36 GLN A 104 ILE A 105 TYR A 106 LEU A 108 SITE 7 AC1 36 WFJ A 202 HOH A 314 HOH A 318 HOH A 328 SITE 8 AC1 36 HOH A 345 HOH A 367 HOH A 371 HOH A 374 SITE 9 AC1 36 HOH A 387 HOH A 399 HOH A 419 HOH A 453 SITE 1 AC2 15 ILE A 7 TRP A 8 ALA A 9 ASP A 29 SITE 2 AC2 15 LEU A 30 PHE A 33 LYS A 34 LEU A 52 SITE 3 AC2 15 HIS A 56 ARG A 62 ILE A 100 TYR A 106 SITE 4 AC2 15 NAP A 201 HOH A 305 HOH A 418 CRYST1 29.430 70.790 36.180 90.00 111.48 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.033979 0.000000 0.013368 0.00000 SCALE2 0.000000 0.014126 0.000000 0.00000 SCALE3 0.000000 0.000000 0.029702 0.00000